HC Wainwright maintains Buy on Anixa Biosciences, $6 target
HC Wainwright & Co. reiterated a Buy rating on Anixa Biosciences and kept a $6.00 price target, implying 122.2% upside versus the $2.70 Sep 21 close.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.